BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17597580)

  • 1. Molecular docking of inhibitors into monoamine oxidase B.
    Harkcom WT; Bevan DR
    Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
    Toprakçí M; Yelekçi K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4438-46. PubMed ID: 16137882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
    Veselovskiĭ AV; Ivanov AS; Medvedev AE
    Vopr Med Khim; 1997; 43(6):527-36. PubMed ID: 9503570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitors and computer modelling of the active site of monoamine oxidase.
    Medvedev AE; Ivanov AS; Veselovsky AV
    Neurobiology (Bp); 2000; 8(2):201-14. PubMed ID: 11061215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
    J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV; Medvedev AE; Tikhonova OV; Skvortsov VS; Ivanov AS
    Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
    Tripathi RK; Goshain O; Ayyannan SR
    ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening.
    Geldenhuys WJ; Darvesh AS; Funk MO; Van der Schyf CJ; Carroll RT
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5295-8. PubMed ID: 20650633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
    Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
    Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.